Relcovaptan (SR-49059) is a non-peptide vasopressin receptor antagonist, selective for the V1A subtype. It has shown positive initial results for the treatment of Raynaud syndrome and dysmenorrhoea, and as a tocolytic, although it is not yet approved for clinical use.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.